Does Ketamine Have Anti-Suicidal Properties? Current Status and Future Directions Rebecca B. PriceSanjay J. Mathew Current Opinion 26 February 2015 Pages: 181 - 188
Epidemiology and Management of Neuropsychiatric Disorders in Behçet’s Syndrome Rosaria TalaricoLaura PalaginiMarta Mosca Therapy in Practice 03 February 2015 Pages: 189 - 196
Antineuronal Antibodies Against Neurotransmitter Receptors and Synaptic Proteins in Schizophrenia: Current Knowledge and Clinical Implications Johann SteinerKolja SchiltzBernhard Bogerts Review Article 28 February 2015 Pages: 197 - 206
Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs Maria Pia AmatoEmilio Portaccio Review Article 14 March 2015 Pages: 207 - 220
Pharmacotherapy of Acute Mania: Monotherapy or Combination Therapy with Mood Stabilizers and Antipsychotics? Iria GrandeEduard Vieta Review Article 25 February 2015 Pages: 221 - 227
Infection Risk in Patients on Multiple Sclerosis Therapeutics Eric M. WilliamsonJoseph R. Berger Review Article 12 March 2015 Pages: 229 - 244
Serotonin–Norepinephrine Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor Use and Risk of Fractures: A New-User Cohort Study Among US Adults Aged 50 Years and Older Amy LanteigneYi-han SheuMatthew Miller Original Research Article 24 February 2015 Pages: 245 - 252
Lurasidone: A Review of Its Use in Adult Patients with Bipolar I Depression Mark SanfordSohita Dhillon Adis Drug Evaluation 20 February 2015 Pages: 253 - 263